SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about newspaper publication

13 Jan 2026 Evaluate
Pursuant to Regulation 30 read with Schedule III part A para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bharat Parenterals has enclosed copies of the following newspaper advertisements published today i.e., January 13, 2026, regarding proposed transfer of shares pursuant to the SEBI circular no. SEBI/HO/MIRSD/MIRSDPoD/P/CIR/2025/97, dated July 2, 2025, allowing the opening of a special window for relodgement of transfer of shares in physical form: 1. Business Standard (English), 2. Vadodara Samachar (Gujarati). The advertisement is also being made available on the Company’s website at www.bplindia.in.

The above information is a part of company’s filings submitted to BSE.

Bharat Parenterals Share Price

1234.70 0.00 (0.00%)
15-Apr-2026 10:20 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.10
Dr. Reddys Lab 1216.00
Cipla 1225.90
Zydus Lifesciences 931.00
Lupin 2336.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×